Jane Ryan
Fortune : 1 221 $ au 31/05/2026
Fortune : 1 221 $ au 31/05/2026
Dr. Jane Ryan is an Independent Non-Executive Director at Neuphoria Therapeutics, Inc., an Independent Non-Executive Director at Idt Australia Ltd., an Independent Non-Executive Director at Bionomics Ltd. and a Member at Australian Institute of Co. Directors.
She is on the Board of Directors at Neuphoria Therapeutics, Inc., Idt Australia Ltd., Robotic Surgery Evolution Ltd., Bionomics Ltd. and Viral Vector Manufacturing Facility Pty Ltd. Dr. Ryan was previously employed as a Non-Executive Director by Anatara Lifesciences Ltd., a Chief Executive Officer by Sementis Ltd., a VP-Product Development & Strategic Marketing by Biota Holdings Pty Ltd., a VP-Product Development & Strategic Marketing by Aviragen Therapeutics, Inc., and a Vice President-Research & Development by Reef Pharmaceuticals Pty Ltd. She also served on the board at Bio Innovation SA, Diabetes Australia-VIC, Diabetes Vaccine Development Centre Ltd., Diabetes Victoria and Veski.
She received her undergraduate degree from The Australian National University and a doctorate degree from Macquarie University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0 % | 20/01/2026 | 230 ( 0 % ) | 1 221 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IDT AUSTRALIA LIMITED | Directeur/Membre du Conseil | 28/01/2022 |
Robotic Surgery Evolution Ltd. | Directeur/Membre du Conseil | 01/11/2021 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Directeur/Membre du Conseil | 01/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| ANATARA LIFESCIENCES LTD | Directeur/Membre du Conseil | 02/10/2023 |
Sementis Ltd.
Sementis Ltd. BiotechnologyHealth Technology Develops next-generation vaccine viral-vector software platform | Directeur Général | 01/01/2017 |
Diabetes Australia-VIC | Directeur/Membre du Conseil | - |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Sales & Marketing | - |
Reef Pharmaceuticals Pty Ltd. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Idt Australia Ltd.
Idt Australia Ltd. Pharmaceuticals: MajorHealth Technology Produces, develops and supplies pharmaceutical products | Health Technology |
Biota Holdings Pty Ltd.
Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie University
Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Bio Innovation SA
Bio Innovation SA Miscellaneous Commercial ServicesCommercial Services Promotes biotechnology development projects | Commercial Services |
Diabetes Australia-VIC | |
Diabetes Vaccine Development Centre Ltd. | |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
Anatara Lifesciences Ltd.
Anatara Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic oral solutions for gastrointestinal diseases in animals and humans | Health Technology |
Veski | |
Sementis Ltd.
Sementis Ltd. BiotechnologyHealth Technology Develops next-generation vaccine viral-vector software platform | Health Technology |
Reef Pharmaceuticals Pty Ltd. | |
Diabetes Victoria | |
Robotic Surgery Evolution Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national